WP Advisors LLC Raises Position in UnitedHealth Group Incorporated $UNH

WP Advisors LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 28.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,569 shares of the healthcare conglomerate’s stock after buying an additional 5,266 shares during the period. UnitedHealth Group makes up 2.1% of WP Advisors LLC’s holdings, making the stock its 12th largest position. WP Advisors LLC’s holdings in UnitedHealth Group were worth $8,138,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Caxton Associates LLP purchased a new position in UnitedHealth Group during the 1st quarter worth approximately $1,792,000. Peloton Wealth Strategists boosted its holdings in shares of UnitedHealth Group by 1.4% in the 1st quarter. Peloton Wealth Strategists now owns 10,320 shares of the healthcare conglomerate’s stock valued at $5,405,000 after acquiring an additional 147 shares during the last quarter. Finally, Empowered Funds LLC raised its holdings in shares of UnitedHealth Group by 8.2% during the first quarter. Empowered Funds LLC now owns 43,709 shares of the healthcare conglomerate’s stock worth $22,893,000 after purchasing an additional 3,310 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. UBS Group increased their price target on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Bank of America raised their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Finally, Barclays upped their price objective on shares of UnitedHealth Group from $386.00 to $391.00 and gave the stock an “overweight” rating in a research report on Monday. Seventeen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $385.75.

UnitedHealth Group Stock Performance

UNH opened at $348.81 on Wednesday. The company has a market cap of $315.97 billion, a price-to-earnings ratio of 18.21, a PEG ratio of 2.06 and a beta of 0.42. The firm’s fifty day simple moving average is $329.71 and its two-hundred day simple moving average is $320.46. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period last year, the company posted $7.15 EPS. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.